Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population‐based cohort study-Reference-Cited by-同舟云学术

Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population‐based cohort study

Published:2015-02-05 Issue:3 Volume:24 Page:256-261
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Antoniou Tony¹²³⁴,Yao Zhan⁴,Camacho Ximena⁴,Mamdani Muhammad M.²³⁴⁵⁶,Juurlink David N.³⁴⁷,Gomes Tara²³⁴⁵

Affiliation:

1. Department of Family and Community Medicine St. Michael's Hospital Toronto Canada

2. Li Ka Shing Knowledge Institute St. Michael's Hospital Toronto Canada

3. University of Toronto Toronto Canada

4. Institute for Clinical Evaluative Sciences Toronto Canada

5. Applied Health Research Centre St. Michael's Hospital Toronto Canada

6. King Saud University Riyadh Saudi Arabia

7. Sunnybrook Research Institute Toronto Canada

Funder

Ontario Ministry of Health and Long-term Care

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3761

Reference32 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease (updated2014). Available at:www.goldcopd.com(last accessed August 8 2014).

2. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

3. Reduced Histone Deacetylase in COPD

4. Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease

5. Histone deacetylases (HDACs): characterization of the classical HDAC family

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19;European Journal of Pharmacology;2021-05

2. A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride;BMC Musculoskeletal Disorders;2018-05-22